Olmesartan/Amlodipine/Hct Eg (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipine/Hct Eg, is a angiotensin II receptor blocker presented as a fixed‑dose combination for oral use. It treats hypertension in adults, often when monotherapy does not achieve target blood pressure. GNH USA supplies Olmesartan/Amlodipine/Hct Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan/Amlodipine/Hct Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/Amlodipine/Hct Eg is used in the management of high blood pressure, acting on the renin‑angiotensin system and vascular smooth‑muscle tone. - Hypertension: helps achieve target blood pressure when combination therapy is required. - Hypertensive heart disease: reduces cardiac workload and risk of progression. - Chronic kidney disease with hypertension: aids in slowing renal function decline associated with elevated blood pressure.

Adverse reactions may vary depending on the individual components and their combined effect.

Common Side Effects: - Dizziness - Headache - Peripheral edema - Flushing - Fatigue - Cough

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Electrolyte disturbances (e.g., hyponatremia, hyperkalemia) - Angio‑angry  - Liver enzyme elevation - Pancrepan  t

When   g   t  d  ... ... ... ... ...   ewline...   ewline  ... …  ewline ... … ... ... ... … ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... … ... ... … … …